Gaviscon vs Omeprazole in the Treatment of Moderate GERD: Discussion – Medscape News

The GOOD trial is the first randomised controlled double-blind, double-dummy trial to directly compare efficacy between an alginate and a PPI with heartburn as the clinical primary endpoint. It showed that Gaviscon® (4 × 10 mL/day) was not inferior to …

Leave a Reply

Your email address will not be published. Required fields are marked *

*